Ischemic hepatitis: widening horizons

Area of Science:

• Hepatology
• Critical Care Medicine
• Nephrology

Background:

• Ischemic hepatitis is a known complication of severe hypotension or cardiac failure.
• Prognosis is typically linked to the underlying cause of hypotension, not the liver dysfunction itself.

Purpose of the Study:

• To report previously undocumented clinical and biochemical abnormalities in ischemic hepatitis.
• To identify key indicators for diagnosing ischemic hepatitis.

Main Methods:

• Retrospective analysis of nine patients diagnosed with ischemic hepatitis.
• Review of clinical and biochemical data until recovery or death.

Main Results:

• All patients showed rapid, significant elevations in aspartate aminotransferase and lactic dehydrogenase, followed by quick normalization.
• Six patients experienced abnormal serum glucose levels, with three requiring temporary insulin therapy.
• All nine patients developed transient renal impairment and six had altered mental status, both resolving spontaneously.
• Pre-existing anemia did not worsen hepatic ischemia manifestations.

Conclusions:

• Ischemic hepatitis should be suspected in patients with recent systemic hypotension.
• Key diagnostic indicators include a massive early rise in lactic dehydrogenase, rapid transaminase decline, and early mild/moderate renal failure.
• Reversible renal failure, mental confusion, and hyperglycemia are common manifestations requiring prompt management.